Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
BMC Cancer|October 5, 2022
Adjuvant effect of IRES-based single-stranded RNA on melanoma immunotherapyHye Won Kwak, So-Hee Hong, Hyo-Jung Park, et al.Advanced Healthcare Materials|November 6, 2024
Novel Less Toxic, Lymphoid Tissue-Targeted Lipid Nanoparticles Containing a Vitamin B5-Derived Ionizable Lipid for mRNA Vaccine DeliverySoyeon Yoo, Muhammad Faisal, Seo-Hyeon Bae, et al.Animal Cells and Systems|June 12, 2025
Comparative immunologic profiling of mRNA and protein-conjugated vaccines: acute inflammatory responses and anti-PEG antibody productionGahyun Roh, Jisun Lee, Hyun-Mee Park, et al.NPJ Vaccines|June 4, 2023
Analyzing immune responses to varied mRNA and protein vaccine sequencesHyeong-Jun Park, Yoo-Jin Bang, Sung Pil Kwon, et al.NPJ Vaccines|November 17, 2025
Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stabilityAyoung Oh, Seonghyun Lee, Hyeong-Jun Park, et al.Vaccine|September 23, 2025
Effective mRNA-based therapy using E7 antigen and IL-12 cytokine in head and neck cancer mice modelsSeonghyun Lee, Jisun Lee, Yu-Sun Lee, et al.The Journal of Infectious Diseases|September 15, 2023
Analysis of the Immunostimulatory Effects of Cytokine-Expressing Internal Ribosome Entry Site-Based RNA Adjuvants and Their ApplicationsYu-Sun Lee, Yoo-Jin Bang, Soyeon Yoo, et al.Scientific Reports|June 8, 2021
Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvantYoo-Jin Bang, So-Hee Hong, Hyo-Jung Park, et al.Toxicology Letters|June 14, 2026
Nonclinical Safety Evaluation Strategies for mRNA/LNPs Platform Agents: Evidence from Comprehensive Animal Toxicity StudiesJae-Hun Ahn, Na-Young Lee, Hee-Jin Bae, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 28, 2025
A systemic evaluation of the effect of dsRNA contamination on mRNA vaccine expression and immunogenicitySohee Jo, Jisun Lee, Sang-In Park, et al.Pageof 3